Tolero Pharmaceuticals Home
Making Meaningful Medicines
Tolero Pharmaceuticals, Inc.,
a clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases.
clear space
Tolero Pharmaceuticals Announces Mechanistic Data Describing the Activity of Alvocidib... Line Tolero Pharmaceuticals to Present Alvocidib Regimen Data at Upcoming Medical Conferences Line Tolero Pharmaceuticals Presents Positive Preclinical Data that Inhibition of AXL Kinase Restores Tumor Response to Retinoic Acid Line Tolero Pharmaceuticals Presents Positive Preclinical Data on Hepcidin Inhibition for the Treatment of Anemia...

Tolero Pharmaceuticals

Tolero PharmaceuticalsTolero Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to alleviating human suffering through the discovery and development of novel therapeutics to treat cancer and other serious human diseases. Our pipeline targets important biological drivers of blood disorders to treat leukemias and anemia. MORE
Learn how Tolero researchers are actively expanding scientific understanding of hematological disease. MORE
See how clinical trials on the use of Alvocidib to treat acute myeloid leukemia (AML) are demonstrating promising results. MORE
Find out how Tolero's pipeline agents offer tremendous opportunities for investors. MORE
clear space